check_circleStudy Completed

Acne vulgaris

Study on efficacy of ethinylestradiol + cyproterone acetate in women with acne papulopustulosa

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Female

Age

16 - 35 Years
  • -

  • -

Trial summary

Enrollment Goal
1011
Trial Dates
November 2002 - November 2003
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Diane 35 (EE/CPA, BAY86-5264)
Accepts Healthy Volunteer
N/A

Trial design

Multicenter, double-blind, randomized parallel group study on efficacy of 0.035 mg ethinylestradiol/2 mg cyproterone acetate and of 0.035 mg ethinylestradiol/2 mg cyproterone acetate in combination with 10 mg cyproterone acetate in comparison to triphasic ethinylestradiol/norgestimate over 6 cycles in women with acne papulopustulosa
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A